Rob Webster

2.9k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Rob Webster is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Rob Webster has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Rob Webster's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Rob Webster is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Rob Webster collaborates with scholars based in United Kingdom, United States and Japan. Rob Webster's co-authors include Manos Perros, Anthony Wood, David A. Price, Mike Westby, Paul Griffin, Blanda Stammen, Malcolm Macartney, Patrick Dorr, Caroline Smith‐Burchnell and Carolyn Napier and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

Rob Webster

26 papers receiving 2.0k citations

Hit Papers

Maraviroc (UK-427,857), a... 2005 2026 2012 2019 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
    2005 909 citations Mike Westby, Rob Webster et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rob Webster 705 657 527 270 267 26 2.1k
Neil R. Hartman 503 0.7× 917 1.4× 1.1k 2.1× 186 0.7× 180 0.7× 41 1.9k
Yuji Iizawa 700 1.0× 652 1.0× 621 1.2× 1.2k 4.4× 319 1.2× 46 2.8k
Peng Zhan 766 1.1× 345 0.5× 495 0.9× 84 0.3× 179 0.7× 87 2.1k
Yi‐Lin Chiu 1.0k 1.5× 178 0.3× 317 0.6× 312 1.2× 452 1.7× 102 2.6k
Andrew Gibson 789 1.1× 285 0.4× 275 0.5× 1.3k 4.7× 330 1.2× 86 3.3k
Maurizio Cianfriglia 1.3k 1.8× 215 0.3× 395 0.7× 340 1.3× 1.2k 4.3× 100 2.5k
Michele Connelly 1.6k 2.3× 319 0.5× 661 1.3× 82 0.3× 763 2.9× 66 3.1k
Serkan Sertel 443 0.6× 447 0.7× 218 0.4× 484 1.8× 288 1.1× 43 1.6k
Riad Agbaria 774 1.1× 302 0.5× 447 0.8× 66 0.2× 291 1.1× 51 2.3k

Countries citing papers authored by Rob Webster

Since Specialization
Citations

This map shows the geographic impact of Rob Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Webster more than expected).

Fields of papers citing papers by Rob Webster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Webster. The network helps show where Rob Webster may publish in the future.

Co-authorship network of co-authors of Rob Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Webster. A scholar is included among the top collaborators of Rob Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Webster. Rob Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parng, Chuenlei, et al.. (2019). Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXaI16L in Preclinical Species. The AAPS Journal. 21(3). 52–52. 3 indexed citations
2.
Parng, Chuenlei, Debra D. Pittman, Katherine Wright, et al.. (2018). Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti–Tissue Factor Pathway Inhibitor Antibody, PF-06741086. Journal of Pharmaceutical Sciences. 107(7). 1995–2004. 28 indexed citations
3.
Jones, Hannah M., Richard P. Butt, Rob Webster, et al.. (2016). Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. Clinical Pharmacokinetics. 55(7). 875–887. 22 indexed citations
4.
Bright, Helen, Paul Cockle, Rob Webster, et al.. (2013). CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And Characterization. Cells. 2(1). 19–42. 4 indexed citations
5.
Brady, Kevin & Rob Webster. (2012). Disposition of Biologics. Advances in pharmacology. 63. 257–277. 6 indexed citations
6.
Pryde, David C., Thien-Duc Tran, Peter Jones, et al.. (2012). Medicinal chemistry approaches to avoid aldehyde oxidase metabolism. Bioorganic & Medicinal Chemistry Letters. 22(8). 2856–2860. 31 indexed citations
7.
Callegari, Ernesto, Bimal Malhotra, Peter J. Bungay, et al.. (2011). A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. British Journal of Clinical Pharmacology. 72(2). 235–246. 111 indexed citations
8.
Mowbray, Charles E., Catherine Burt, Romuald Corbau, et al.. (2009). Pyrazole NNRTIs 1: Design and initial optimisation of a novel template. Bioorganic & Medicinal Chemistry Letters. 19(19). 5599–5602. 30 indexed citations
9.
Walker, Don K., John D. Davis, Christopher Houle, I. Gardner, & Rob Webster. (2009). Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerations. Xenobiotica. 39(7). 534–543. 10 indexed citations
10.
Mowbray, Charles E., Catherine Burt, Romuald Corbau, et al.. (2009). Pyrazole NNRTIs 4: Selection of UK-453,061 (lersivirine) as a Development Candidate. Bioorganic & Medicinal Chemistry Letters. 19(20). 5857–5860. 91 indexed citations
11.
Hosea, Natilie, Wendy T. Collard, Susan Cole, et al.. (2009). Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches. The Journal of Clinical Pharmacology. 49(5). 513–533. 205 indexed citations
12.
Mowbray, Charles E., Romuald Corbau, Michael L. Hawes, et al.. (2009). Pyrazole NNRTIs 3: Optimisation of physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 19(19). 5603–5606. 24 indexed citations
13.
Webster, Rob, et al.. (2008). PEGylation of somatropin (recombinant human growth hormone): Impact on its clearance in humans. Xenobiotica. 38(10). 1340–1351. 52 indexed citations
14.
Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2008). The discovery of adamantyl-derived, inhaled, long acting β2-adrenoreceptor agonists. Bioorganic & Medicinal Chemistry Letters. 18(4). 1280–1283. 28 indexed citations
15.
Jones, Lyn H., Romuald Corbau, Duncan A. Hay, et al.. (2008). Optimization of 5‐Aryloxyimidazole Non‐Nucleoside Reverse Transcriptase Inhibitors. ChemMedChem. 3(11). 1756–1762. 8 indexed citations
16.
Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2007). The discovery of indole-derived long acting β2-adrenoceptor agonists for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 17(22). 6188–6191. 22 indexed citations
17.
Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2007). The discovery of long acting β2-adrenoreceptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 4012–4015. 29 indexed citations
18.
Betts, Alison, Iain Gardner, David A. Fox, et al.. (2007). Impact of Physicochemical and Structural Properties on the Pharmacokinetics of a Series of α1L-Adrenoceptor Antagonists. Drug Metabolism and Disposition. 35(8). 1435–1445. 5 indexed citations
19.
Webster, Rob, Philip L. Harris, Ned R. Siegel, et al.. (2006). PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies. Drug Metabolism and Disposition. 35(1). 9–16. 271 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil R. Hartman Breakdown of academic impact, for papers by Yuji Iizawa Breakdown of academic impact, for papers by Peng Zhan Breakdown of academic impact, for papers by Yi‐Lin Chiu Breakdown of academic impact, for papers by Andrew Gibson Breakdown of academic impact, for papers by Maurizio Cianfriglia Breakdown of academic impact, for papers by Michele Connelly Breakdown of academic impact, for papers by Serkan Sertel Breakdown of academic impact, for papers by Riad Agbaria
Rankless by CCL
2026